Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is an aggressive cancer with a poor prognosis. The role of autophagy and the prognostic value of autophagic genes are largely unknown in HCC. Here, we showed decreased expression of autophagic genes and their corresponding autophagic activity and increased expression of the antiapoptotic gene Bcl-xL in HCC cell lines compared with a normal hepatic cell line. We also found decreased expression of the autophagic gene Beclin 1 in 44 HCC tissue samples compared with adjacent nontumor tissues. In addition, we found that the most aggressive malignant HCC cell lines and HCC tissues with recurrent disease displayed much lower autophagic levels, especially when Bcl-xL was overexpressed. Interestingly, in a tissue microarray study consisting of 300 HCC patients who underwent curative resection, the expression of Beclin 1 was only significantly correlated with disease-free survival (DFS; P < 0.0001) and overall survival (OS; P < 0.0001) in the Bcl-xL(+) group. Multivariate and univariate analyses also revealed that Beclin 1 expression was an independent predictor for DFS and OS in Bcl-xL(+) patients. In addition, we found a significant correlation between Beclin 1 expression and tumor differentiation in Bcl-xL(+) but not in Bcl-xL(-) HCC patients. In conclusion, our data showed expression of autophagic genes and their corresponding autophagic activities were suppressed in HCC. The autophagy defects synergized with altered apoptotic activity might facilitate tumor malignant differentiation, which results in a more aggressive cancer cell phenotype and poor prognosis of HCC.

[1]  J. Ryerse,et al.  BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells , 2008, Oncogene.

[2]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[3]  Robin Mathew,et al.  Role of autophagy in cancer , 2007, Nature Reviews Cancer.

[4]  J. J. Mul,et al.  Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis , 2007, Nature Cell Biology.

[5]  Guido Kroemer,et al.  Self-eating and self-killing: crosstalk between autophagy and apoptosis , 2007, Nature Reviews Molecular Cell Biology.

[6]  Pascal Barbry,et al.  GAPDH and Autophagy Preserve Survival after Apoptotic Cytochrome c Release in the Absence of Caspase Activation , 2007, Cell.

[7]  J. Richardson,et al.  Cardiac autophagy is a maladaptive response to hemodynamic stress. , 2007, The Journal of clinical investigation.

[8]  E. White,et al.  Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. , 2007, Genes & development.

[9]  C. López-Otín,et al.  Tissue-specific Autophagy Alterations and Increased Tumorigenesis in Mice Deficient in Atg4C/Autophagin-3* , 2007, Journal of Biological Chemistry.

[10]  Zhao-You Tang,et al.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. White,et al.  Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.

[12]  B. Rohrer,et al.  Apoptosis and Autophagy in Photoreceptors Exposed to Oxidative Stress , 2007, Autophagy.

[13]  B. Levine,et al.  Cell biology: Autophagy and cancer , 2007, Nature.

[14]  Wen-Lin Kuo,et al.  Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. , 2007, Cancer research.

[15]  G. Evan,et al.  Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.

[16]  E. White,et al.  Role of Autophagy in Cancer: Management of Metabolic Stress , 2007, Autophagy.

[17]  J. Hardwick,et al.  Upgrading the BCL-2 Network , 2006, Nature Cell Biology.

[18]  Sheung Tat Fan,et al.  Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. , 2006, Cancer research.

[19]  Kevin Bray,et al.  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. , 2006, Cancer cell.

[20]  B. Oh,et al.  Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG , 2006, Nature Cell Biology.

[21]  Shivendra V. Singh,et al.  Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. , 2006, Cancer research.

[22]  M. Jo,et al.  A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. , 2006, Journal of hepatology.

[23]  Chi Li,et al.  Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis , 2005, Cell.

[24]  S. Pattingre,et al.  The Evolutionarily Conserved Domain of Beclin 1 is Required for Vps34 Binding, Autophagy, and Tumor Suppressor Function , 2005, Autophagy.

[25]  Craig B. Thompson,et al.  Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes , 2004, Nature Cell Biology.

[26]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[27]  Ajjai Alva,et al.  Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8 , 2004, Science.

[28]  Yan Li,et al.  Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics , 2004, Journal of Cancer Research and Clinical Oncology.

[29]  E. Chun,et al.  Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. , 2004, Biochemical and biophysical research communications.

[30]  Govind Bhagat,et al.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.

[31]  Arnold J. Levine,et al.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Ze-Guang Han,et al.  A novel liver‐specific zona pellucida domain containing protein that is expressed rarely in hepatocellular carcinoma , 2003, Hepatology.

[33]  X. Wang,et al.  Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.

[34]  S. Friedman,et al.  Expression and role of Bcl‐xL in human hepatocellular carcinomas , 2001, Hepatology.

[35]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[36]  S. Emr,et al.  Autophagy as a regulated pathway of cellular degradation. , 2000, Science.

[37]  S. Fan,et al.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.

[38]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[39]  D L Pincus,et al.  Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. , 1999, Genomics.

[40]  M. Imamura,et al.  Immunohistochemical Analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 Expression in Pancreatic Cancers , 1999, Oncology.

[41]  K. Chang,et al.  Detection of a novel lactate dehydrogenase isozyme and an apparent differentiation-associated shift in isozyme profile in hepatoma cell lines. , 1994, Cancer letters.

[42]  M. Noteborn,et al.  Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor , 2007, Cancer Gene Therapy.

[43]  J. Llovet,et al.  Hepatocellular carcinoma: present status and future prospects. , 2003, Journal of hepatology.

[44]  S. Ye,et al.  Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray , 2002, Journal of Cancer Research and Clinical Oncology.